Sai Life Sciences to exhibit at CPhI Worldwide 2017

SAI Life Sciences is a strategic contract development and manufacturing service provider, with a broad technology platform tailored to accelerate discovery, development and commercial supply of regulatory starting materials (RSM), intermediates and new chemical entities (NCE) of pharma and biotech companies

The space industry inspires Sai Life Sciences with a new process engineering and manufacturing facilities.

Sai has also launched a new video to showcase its state of the art manufacturing block and enhanced process engineering lab.



As part of the company’s continuous investment programme, Sai have added a new 100 cubic meter GMP plant (block 7) in Bidar, India. In addition a new process engineering lab and pilot plan was added to enable development of robust NCE processes. As a result of these strategic investment, Sai is even better placed to manufacture NCE’s for pharma’s innovations.

Left: block 7 outside, Right: Sai PE lab

The Bidar site offers a scalable range of capacities using some of the most modern equipment in India. From here they serve the most highly regulated markets in the world. The site is an FDA and PMDA registered and accepted. It is also a zero-discharge site meeting the highest environmental standards.

Block 7 reactors

The new video is a brief introduction to the company which is training motivated personnel with modern equipment to meet the increasing standards of world compliance and innovator pharma.

Taking a leaf from the world of ‘Space’ many parallels are seen in performance of highly skilled and trained personnel and engineering to achieve escape velocity for the payload of a rocket and delivering complex chemistry in modern medicines.

Come and see us at CPhI Frankfurt at booth 110D11

Companies